Moleculin Biotech (MBRX) Current Assets (2015 - 2026)
Moleculin Biotech's Current Assets came in at $8.72 million for Q2 2026, down 3.9% from $9.08 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Current Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech's Current Assets was $9.69 million, up 86.5% from FY2024.
- Current Assets carries a five-year compound annual growth rate of -10.8% (FY2020 to FY2025).
- Going back by year, Current Assets was $5.19 million in FY2024 (-80.2%), $26.27 million in FY2023 (-42.4%), $45.6 million in FY2022 (-37.1%) and $72.5 million in FY2021 (+321.5%).
- The five-year range for quarterly Current Assets is $5.19 million (Q4 2024) to $77.07 million (Q3 2021).
- Year-over-year, Current Assets increased in 1 of the last seven quarters, with an average decline of 24.6%.
- The fastest year-over-year change in Current Assets over five years came in Q3 2021 (growth of 405.4%), and the weakest in Q4 2024 (a decline of 80.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Moleculin Biotech | 2.84 Mn | 2.84 Mn | - | 8.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.72 Mn |
| Dec 31, 2025 | 9.69 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Jun 30, 2025 | 9.08 Mn |
| Mar 31, 2025 | 9.34 Mn |
| Dec 31, 2024 | 5.19 Mn |
| Sep 30, 2024 | 11.61 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 18.96 Mn |
| Dec 31, 2023 | 26.27 Mn |
| Sep 30, 2023 | 27.60 Mn |
| Jun 30, 2023 | 35.38 Mn |
| Mar 31, 2023 | 39.29 Mn |
| Dec 31, 2022 | 45.60 Mn |
| Sep 30, 2022 | 53.49 Mn |
| Jun 30, 2022 | 61.32 Mn |
| Mar 31, 2022 | 67.26 Mn |
| Dec 31, 2021 | 72.50 Mn |
| Sep 30, 2021 | 77.07 Mn |
| Jun 30, 2021 | 81.84 Mn |
API Access
Moleculin Biotech Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();